Intel Corp Chairman Omar Ishrak (pictured) is planning to raise funds for a blank-check firm targeting deals in the health technology sector, Bloomberg reports, citing people with knowledge of the matter.
Ishrak, who previously ran medical device giant Medtronic, could file public registration documents with the SEC today. Ishrak is said to be targeting to raise about $750 million to $1 billion for the SPAC.
Goldman Sachs Group Inc is leading preparations for the IPO, the sources said. Hedge fund manager Joshua Fink, who is the son of BlackRock’s Larry Fink, and Medtronic executive Jean Nehme will have senior roles at the blank-check company, the people said. Ishrak is poised to be chairman. Read more.
